These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 33093086)
1. Global trial eliminates drugs, pivots to new ones. Kupferschmidt K Science; 2020 Oct; 370(6515):388-389. PubMed ID: 33093086 [No Abstract] [Full Text] [Related]
2. A Potential Antiviral Treatment for COVID-19: Remdesivir. O'Malley PA Clin Nurse Spec; 2020; 34(6):257-260. PubMed ID: 33009111 [No Abstract] [Full Text] [Related]
3. Remdesivir: a pendulum in a pandemic. Schwartz IS; Heil EL; McCreary EK BMJ; 2020 Nov; 371():m4560. PubMed ID: 33234523 [No Abstract] [Full Text] [Related]
4. Remdesivir (Veklury) for COVID-19. Med Lett Drugs Ther; 2020 Nov; 62(1612):186-188. PubMed ID: 33443491 [No Abstract] [Full Text] [Related]
5. Assessing the evidence on remdesivir. Trøseid M; Hites M; Barratt-Due A; Ader F; Yazdanpanah Y Lancet Infect Dis; 2021 Dec; 21(12):1630-1631. PubMed ID: 34838222 [No Abstract] [Full Text] [Related]
6. FDA Approval of Remdesivir - A Step in the Right Direction. Rubin D; Chan-Tack K; Farley J; Sherwat A N Engl J Med; 2020 Dec; 383(27):2598-2600. PubMed ID: 33264539 [No Abstract] [Full Text] [Related]
7. COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19. Med Lett Drugs Ther; 2022 Feb; 64(1644):31-32. PubMed ID: 35171898 [No Abstract] [Full Text] [Related]
8. Commentary: "Emergency Use Authorization for Remdesivir: A Pediatric Perspective". Noel GJ; Connor E Pediatr Infect Dis J; 2020 Sep; 39(9):e234. PubMed ID: 32639464 [No Abstract] [Full Text] [Related]
9. In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality. Zhang R; Mylonakis E Ann Intern Med; 2021 Feb; 174(2):JC17. PubMed ID: 33524282 [TBL] [Abstract][Full Text] [Related]
10. 'A very, very bad look' for remdesivir. Cohen J; Kupferschmidt K Science; 2020 Nov; 370(6517):642-643. PubMed ID: 33154114 [No Abstract] [Full Text] [Related]
11. Early remdesivir treatment in COVID-19: Why wait another day? Cubeddu LX; Cubeddu RJ J Med Virol; 2021 Jul; 93(7):4078-4080. PubMed ID: 33511655 [No Abstract] [Full Text] [Related]
13. Remdesivir (Veklury) for the Treatment of COVID-19 in Hospitalized Patients. Odeti S; Yellepeddi VK Am Fam Physician; 2021 Sep; 104(3):311-312. PubMed ID: 34523893 [No Abstract] [Full Text] [Related]
14. What Do We Know About Remdesivir Drug Interactions? Yang K Clin Transl Sci; 2020 Sep; 13(5):842-844. PubMed ID: 32402130 [No Abstract] [Full Text] [Related]
17. Remdesivir for patients with COVID-19. Wu PE; Morris AM CMAJ; 2021 Jan; 193(4):E125. PubMed ID: 33408097 [No Abstract] [Full Text] [Related]
18. Remdesivir for the treatment of COVID-19 in pregnancy. Lampejo T J Med Virol; 2021 Jul; 93(7):4114-4119. PubMed ID: 33788273 [No Abstract] [Full Text] [Related]
19. Remdesivir in The Treatment of COVID-19. Rosenberg K Am J Nurs; 2021 Jan; 121(1):55. PubMed ID: 33350698 [TBL] [Abstract][Full Text] [Related]
20. Remdesivir for COVID-19 in Europe: will it provide value for money? Dal-Ré R; Banzi R; Georgin-Lavialle S; Porcher R; Sofat R; Zeitlinger M; Rosendaal FR Lancet Respir Med; 2021 Feb; 9(2):127-128. PubMed ID: 33341157 [No Abstract] [Full Text] [Related] [Next] [New Search]